MAPT and Alzheimer disease: Alzheimer’s disease (AD) is characterized by extracellular amyloid β (Aβ)-containing plaques and intracellular neurofibrillary tangles (NFTs) consisting of aggregated phosphorylated-tau, and is accompanied by synaptic and neuronal failure and cognitive deficits [1].